Jemperli 50 mg/mL
dostarlimab · INJECTION · GlaxoSmithKline LLC
No Recall History
Plain English
Jemperli is a injection containing dostarlimab at 50 mg/mL, taken intravenous. Manufactured by GlaxoSmithKline LLC.
Key Facts
- Brand Name
- Jemperli
- Generic Name
- dostarlimab
- NDC Code (Product)
0173-0898- Manufacturer
- GlaxoSmithKline LLC
- Strength
- 50 mg/mL
- Dosage Form
- INJECTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA761174
- Drug Class
- Programmed Death Receptor-1 Blocking Antibody [EPC]
- Marketing Start
- 04/22/2021
Recall History
No Recall HistoryFrequently Asked Questions
What is Jemperli used for?
Jemperli contains dostarlimab. It is a injection taken intravenous. Consult your doctor for specific uses.
Is Jemperli a controlled substance?
Jemperli is not classified as a controlled substance by the DEA.
What is the generic name for Jemperli?
The generic name for Jemperli is dostarlimab. There are no other listed brand versions of dostarlimab.
What is the NDC code for Jemperli 50 mg/mL?
The NDC (National Drug Code) for Jemperli 50 mg/mL is 0173-0898, listed by GlaxoSmithKline LLC.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)